Fahrleitner-Pammer, Astrid

Affiliations (1)

Name	Count	Oldest	Newest
Medical University of Graz	7	2007	2021

Papers (7)

Year	Article	Times Cited	Times Cited (no self-citations)
2007	Stepan JJ, Burr DB, Pavo I, Sipos A, Michalska D, Li J, Fahrleitner-Pammer A, Petto H, Westmore M, Michalsky D, Sato M, Dobnig H. Low bone mineral density is associated with bone microdamage accumulation in postmenopausal women with osteoporosis. Bone. September 2007;41(3):378-385.	23	19
2021	Malle O, Borgstroem F, Fahrleitner-Pammer A, Svedbom A, Dimai SV, Dimai HP. Mind the gap: incidence of osteoporosis treatment after an osteoporotic fracture: results of the Austrian branch of the International Costs and Utilities Related to Osteoporotic Fractures Study (ICUROS). Bone. January 2021;142:115071.	1	1
2020	Geusens P, Kendler DL, Fahrleitner-Pammer A, López-Romero P, Marin F. Distribution of prevalent and incident vertebral fractures and their association with bone mineral density in postmenopausal women in the teriparatide versus risedronate vero clinical trial. Calcif Tiss Int. June 2020;106(6):646-654.	1	0
2010	Reid IR, Miller PD, Brown JP, Kendler DL, Fahrleitner-Pammer A, Valter I, Maasalu K, Bolognese MA, Woodson G, Bone H, Ding B, Wagman RB, San Martin J, Ominsky MS, Dempster DW; Denosumab Phase 3 Bone Histology Study Group. Effects of denosumab on bone histomorphometry: the FREEDOM and STAND studies. J Bone Miner Res. October 2010;25(10):2256-2265.	19	12
2018	Kendler DL, Marin F, Zerbini CAF, Russo LA, Greenspan SL, Zikan V, Bagur A, Malouf-Sierra J, Lakatos P, Fahrleitner-Pammer A, Lespessailles E, Minisola S, Body JJ, Geusens P, Möricke R, López-Romero P. Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial. Lancet. January 20, 2018;391(10117):230-240.	29	24
2017	Bone HG, Wagman RB, Brandi ML, Brown JP, Chapurlat R, Cummings SR, Czerwiński E, Fahrleitner-Pammer A, Kendler DL, Lippuner K, Reginster J-Y, Roux C, Malouf J, Bradley MN, Daizadeh NS, Wang A, Dakin P, Pannacciulli N, Dempster DW, Papapoulos S. 10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension. Lancet Diabetes Endocrinol. July 2017;5(7):513-523.	47	35
2020	Body J-J, Marin F, Kendler DL, Zerbini CAF, López-Romero P, Möricke R, Casado E, Fahrleitner-Pammer A, Stepan JJ, Lespessailles E, Minisola S, Geusens P. Efficacy of teriparatide compared with risedronate on FRAX^®-defined major osteoporotic fractures: results of the VERO clinical trial. Osteoporos Int. October 2020;31(10):1935-1942.	0	0

Collaborators (32)

Name	Count	Oldest	Newest
Chapurlat, Roland	1	2017	2017
Brandi, Maria Luisa	1	2017	2017
Kendler, David L.	5	2010	2020
Miller, Paul D.	1	2010	2010
Marin, Fernando	3	2018	2020
Lakatos, Peter A.	1	2018	2018
San Martin, Javier	1	2010	2010
Zerbini, Cristiano A. F.	2	2018	2020
Cummings, Steven R.	1	2017	2017
Svedbom, Axel	1	2021	2021
Lespessailles, Eric	2	2018	2020
Brown, Jacques P.	2	2010	2017
Pannacciulli, Nicola	1	2017	2017
Roux, Christian	1	2017	2017
Bolognese, Michael A.	1	2010	2010
Greenspan, Susan L.	1	2018	2018
Li, Jiliang	1	2007	2007
Wagman, Rachel B.	2	2010	2017
Czerwiński, Edward	1	2017	2017
Borgström, Fredrik	1	2021	2021
Reginster, Jean-Yves	1	2017	2017
Papapoulos, Socrates E.	1	2017	2017
Reid, Ian R.	1	2010	2010
Dempster, David W.	2	2010	2017
Body, Jean-Jacques	2	2018	2020
Minisola, Salvatore	2	2018	2020
Geusens, Piet P. M. M.	3	2018	2020
Ominsky, Michael S.	1	2010	2010
Bone, Henry G.	2	2010	2017
Sato, Masahiko	1	2007	2007
Burr, David B.	1	2007	2007
Lippuner, Kurt	1	2017	2017